MENU
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurocrine Biosciences (NBIX) Ownership - Who owns Neurocrine Biosciences?
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
13.18B
P/E Ratio
39.32
Total Cash
975.6M
Projected Growth
0.36
Total Debt
439.1M
Revenue
2.51B
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash/Share
9.84
Total Debt/Equity
N/A
Revenue/Share
24.44 USD as % of share price
Fundamentals
NBIX
Capitalization
13.2B
P/E Ratio
39.32
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash
976M
Total Cash/Share
9.84
Total Debt
439M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.36
Revenue/Share (as % of the share price)
24.44%
Revenue
2.51B
ROE
N/A
Book Value
2.69B
P/B Ratio
4.89
Cash Flow
N/A
Earnings
3.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
3.20
Current Revenue Per Employee
381944.44
Dividends Per Share - Security
N/A
EBITDA
557M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.36
Revenue To Assets
9.68
Shares Held By Institutions
19.8B
Shares Outstanding - Current
99.2M
Total Liabilities
1.2B
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.637
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBIX showed earnings on July 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a product based biopharmaceutical company
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com